Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alan Meds vs PauseRX

Alan Meds
Graded #99

Higher grade

vs+2.5999999999999943
PauseRX
Graded #150

Lower grade

The verdict

Alan Meds takes it — 71.1/100 to 68.5/100.

Alan Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth platform offering compounded semaglutide and tirzepatide with multiple administration formats including microdosing and oral options.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlan Meds +6
72
66
Dose & formulationPauseRX +10
75
85
Clinical oversightPauseRX +1
82
83
Labs & monitoringAlan Meds +1
53
52
FulfillmentAlan Meds +17
78
61
Contract termsAlan Meds +14
55
41
Alan Meds · left barPauseRX · right bar

The numbers

MetricAlan MedsPauseRX
WeighScore71.1/10068.5/100
GradeCC
Scorecard rank#99#150
Semaglutide$158/mo (compounded)$199/mo
Tirzepatide$295/mo (compounded)$249/mo (starting dose, compounded)
Coverage46 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Alan Meds

Graded #99 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Where it loses points

  • Limited public information on program details
PauseRX

Graded #150 · C

Strengths

  • Names its 503A pharmacy partner (Strive Pharmacy, Gilbert AZ) — buyers can independently verify its licensure
  • Names its physician network (Beluga Health) — you can research the clinical platform handling your prescriptions
  • Publishes the FDA compounded-medication disclaimer
  • Corporate legal entity disclosed (PauseRX, Inc.) — uncommon for direct-to-consumer GLP-1 platforms
  • Flat $199 'all doses' compounded semaglutide pricing — no per-tier escalation

Where it loses points

  • States served not listed — site claims nationwide, but you must contact support to confirm availability
  • Restrictive cancellation policy — orders can't be changed or canceled once submitted, and medications can't be returned
  • No named medical director (Beluga Health is the network, not a named MD)
  • LegitScript certification number not shown — badge only, so no direct lookup
  • Insurance not accepted — cash-pay only; HSA/FSA eligibility not confirmed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard